Further evaluation into this prominent domain within HACE1 can also potentially identify abnormalities in substrate recognition and binding the AR domain typically takes on, which can lead towards the development of neurodegenerative disease treatment. This evidence concerns the gene HACE1 and neurodegenerative disease.